NPGC(600713.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
NPGC
600713.SH
Nanjing Pharmaceutical Group Company Limited engages in the drug distribution businesses in China. It also involved in the wholesale and retail of medical device distribution; pharmaceutical logistics; and internet drug retail business. The company was formerly known as NanJing Pharmaceutical Company Limited and change its name to Nanjing Pharmaceutical Group Company Limited in December 2025. Nanjing Pharmaceutical Group Company Limited was founded in 1951 and is based in Nanjing, China.
346.11 B
600713.SHMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
Health Care DistributorsIndustry
Industry Ranking12/23
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE8.65%B
    • Profit Margin1.14%C
    • Gross Margin6.28%E
  • Growth ScoreC
    • Revenue YoY1.06%C
    • Net Profit YoY5.63%C
    • Total Assets YoY6.05%C
    • Net Assets YoY5.71%C
  • Cash ScoreD
    • Cash Flow Margin-241.50%E
    • OCF YoY1.06%C
  • Operating ScoreA
    • Turnover1.58A
  • Debt ScoreE
    • Gearing Ratio76.16%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    NPC released its performance for the first three quarters, with a net profit attributable to the parent company of 402 million yuan, a year-on-year decrease of 9.03%

    Zhitong·
    SH
    600713
    -2.30%
    Zhitong·
    SH
    600713
    -2.30%

    NPC: Completed the repurchase of 17,999,900 shares

    Zhitong·
    SH
    600713
    -2.30%
    Zhitong·
    SH
    600713
    -2.30%

    NPC: Will repay the principal and interest of 500 million yuan in ultra-short-term financing bonds

    Zhitong·
    SH
    600713
    -2.30%
    Zhitong·
    SH
    600713
    -2.30%

    NPC: The cumulative conversion amount of Nanjing Pharmaceutical's convertible bonds is 66,000 yuan

    Zhitong·
    SH
    600713
    -2.30%
    Zhitong·
    SH
    600713
    -2.30%

    NPC disclosed the progress of its centralized bidding repurchase of shares, having repurchased shares worth 80.2576 million yuan

    Zhitong·
    SH
    600713
    -2.30%
    Zhitong·
    SH
    600713
    -2.30%
    © 2026 Longbridge｜Disclaimer